Browse clinical instruments

…ditional advice needed. The primary outcome measure will be the McGill Pain Questionnaire revised (SF-MPQ-2). Outcome measures will be collected at basel…

…ariable Cox proportional hazards models, adjusted for age, sex, ECOG performance status, and line of therapy, were used to evaluate associations with o…

…r depression is very likely.14Anxiety The German version of the GAD-7 15 was used to measure generalized anxiety. It consists of 7 it…

… performed by combining the healthcare resource cost and 1-year EQ-5D (giving a quality-adjusted life-year (QALY)) using statistical …

…ive PsA was defined as DAS28-CRP≥2.6 (n=34) and inactive PsA as DAS28-CRP<2.6 (n=75).Results Pre-eclampsia was most frequent in women…

…til December 30, 2024. Primary outcomes included a reduction in National Institutes of Health Stroke Scale (NIHSS) at various time points and functional outcomes as measu…

…esions (CK7/CK14) and FcRL4+ B cells. Pain was assessed using a visual analogue scale (VAS) from 0 to 10. Findings were matched with clinical data.Re…

…was calculated using an anchor-based approach, with the EuroQol-Visual Analogue Scale (EQ-VAS) as the anchor. Frailty index (FI), defined as a 35-ite…

… set at 6 PRWE points. Key secondary endpoints will include the Numeric Rating Scale for pain, patient satisfaction, quality of life (EQ-5D-5L Index…

…ucosal atomization device. The primary endpoint is reduction in Numeric Rating Scale (NRS, 0–10) score at 10 minutes after first administration of s…

…pturing sociodemographic and professional characteristics. The ‘Hospital Anxiety and Depression scale’ (HADS) was used to screen for anxiety and depression symptoms.…

… treatment. This study reports an exploratory analysis of EQ-5D visual analogue scale (EQ VAS) outcomes at 144W of BLV 2 mg treatment among patients …